Recombinant Protein Production - IBES®Technology

Following more than a decade of developing, ALGENEX introduced the IBES® technology in 2005, a leading recombinant protein production system. IBES® is a non-fermentative industrial recombinant protein production process that uses two key components, the widely used AcNPV baculovirus vector and the continuous cycle lepidopter Trichoplusia ni. The IBES® technology, developed by ALGENEX, is the most advantageous and efficient baculovirus-based methodology to produce any kind of functional recombinant protein by the use of insects as small living biofactories. IBES® technology can be used to produce vaccines, diagnostics, therapeutic molecules and other protein-based products. Highly versatile, easy and unlimited scaling up, fast development times, clean and extremely cost-efficient, are some of the important advantages that IBES® technology can offer to the pharmaceutical industry

The IBES® technology, developed by ALGENEX, is the most advantageous and efficient baculovirus-based methodology to produce any kind of functional recombinant protein by the use of insects as small living biofactories. IBES® technology can be used to produce vaccines, diagnostics, therapeutic molecules and other protein-based products.

Copyright © 2010 Alternative Gene Expression S.L. (ALGENEX) . All rights reserved. Terms and Conditions
Centro empresarial - Parque Científico y Tecnológico de la Universidad Politécnica de Madrid - Campus de Montegancedo – 28223.Pozuelo de Alarcón - Madrid – Spain.
Phone: +34 91 452 49 41/42 - Fax: +34 91 347 87 71 - info@algenex.es